Your browser doesn't support javascript.
loading
Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor.
Saif, Muhammad Wasif; Smith, Melissa Hennessey; Maloney, Antonia; Diasio, Robert B.
Affiliation
  • Saif MW; Division of Hematology/Oncology and Experimental Therapeutics, Tufts Cancer Center- Tufts Medical Center, Boston, MA, USA (Muhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney), USA.
  • Smith MH; Division of Hematology/Oncology and Experimental Therapeutics, Tufts Cancer Center- Tufts Medical Center, Boston, MA, USA (Muhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney), USA.
  • Maloney A; Division of Hematology/Oncology and Experimental Therapeutics, Tufts Cancer Center- Tufts Medical Center, Boston, MA, USA (Muhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney), USA.
  • Diasio RB; Mayo Clinic Cancer Center, Rochester, MN (Robert B. Diasio), USA.
Ann Gastroenterol ; 29(4): 551-556, 2016.
Article in En | MEDLINE | ID: mdl-27708529
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Ann Gastroenterol Year: 2016 Document type: Article Affiliation country: United States Country of publication: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Ann Gastroenterol Year: 2016 Document type: Article Affiliation country: United States Country of publication: Greece